SHAYNA GLISTA: Open Payments
NPI 1679125876 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,903 in 146 payments from 14 companies in 2025. Trend: 2023 $1,639 · 2024 $1,663 · 2025 $1,903
Food & beverage: $1,903
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 30 | $427 |
| Vanda Pharmaceuticals Inc. | 32 | $403 |
| Otsuka America Pharmaceutical, Inc. | 21 | $245 |
| ABBVIE INC. | 19 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $201 |
| Corium, LLC | 7 | $87 |
| Almatica Pharma LLC | 4 | $72 |
| Lundbeck LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: Dyanavel XR, FANAPT, REXULTI, VRAYLAR, CAPLYTA, Azstarys, LOREEV XR, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
